A study of the efficacy and safety to rituximab in treating adult onset refractory nephrotic syndrome
Not Applicable
- Conditions
- Refractory nephrotic syndrome
- Registration Number
- JPRN-UMIN000021143
- Lead Sponsor
- Fujita Health University School of Medicine, Department of Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe hypersensitivity to the component of rituximab or products derived from mouse protein. 2. Positive serology for HBs antigen or HBv-DNA 3. Active infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method